Literature DB >> 2926492

Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study.

L M Auer1, W Deinsberger, K Niederkorn, G Gell, R Kleinert, G Schneider, P Holzer, G Bone, M Mokry, E Körner.   

Abstract

A controlled randomized study of endoscopic evacuation versus medical treatment was performed in 100 patients with spontaneous supratentorial intracerebral (subcortical, putaminal, and thalamic) hematomas. Patients with aneurysms, arteriovenous malformations, brain tumors, or head injuries were excluded. Criteria for inclusion were as follows: patients' age between 30 and 80 years; a hematoma volume of more than 10 cu cm; the presence of neurological or consciousness impairment; the appropriateness of surgery from a medical and anesthesiological point of view; and the initiation of treatment within 48 hours after hemorrhage. The criteria of randomization were the location, size, and side of the hematoma as well as the patient's age, state of consciousness, and history of hypertension. Evaluation of outcome was performed 6 months after hemorrhage. Surgical patients with subcortical hematomas showed a significantly lower mortality rate (30%) than their medically treated counterparts (70%, p less than 0.05). Moreover, 40% of these patients had a good outcome with no or only a minimal deficit versus 25% in the medically treated group; the difference was statistically significant for operated patients with no postoperative deficit (p less than 0.01). Surgical patients with hematomas smaller than 50 cu cm made a significantly better functional recovery than did patients of the medically treated group, but had a comparable mortality rate. By contrast, patients with larger hematomas showed significantly lower mortality rates after operation but had no better functional recovery than the medically treated group. This effect from surgery was limited to patients in a preoperatively alert or somnolent state; stuporous or comatose patients had no better outcome after surgery. The outcome of surgical patients with putaminal or thalamic hemorrhage was no better than for those with medical treatment; however, there was a trend toward better quality of survival and chance of survival in the operated group.

Entities:  

Mesh:

Year:  1989        PMID: 2926492     DOI: 10.3171/jns.1989.70.4.0530

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  107 in total

1.  Intracerebral Hemorrhage.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

2.  Practical application of intraoperative ultrasound imaging.

Authors:  V van Velthoven; L M Auer
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

3.  1.32 microns Nd:YAG laser during neurosurgical procedures experience with about 70 patients operated on with the MC 2100 unit.

Authors:  F X Roux; B Devaux; L Merienne; C Cioloca; J P Chodkiewicz
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 4.  Spontaneous intracerebral haemorrhage.

Authors:  A D Mendelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

5.  Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement.

Authors:  Paul Vespa; David McArthur; Chad Miller; Kristine O'Phelan; John Frazee; Chelsea Kidwell; Jeffery Saver; Sidney Starkman; Neil Martin
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  The STICH trial: the end of surgical intervention for supratentorial intracerebral hemorrhage?

Authors:  Katja E Wartenberg; Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 5.081

7.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

8.  Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.

Authors:  Maged D Fam; Daniel Hanley; Agnieszka Stadnik; Hussein A Zeineddine; Romuald Girard; Michael Jesselson; Ying Cao; Lynn Money; Nichol McBee; Amanda J Bistran-Hall; W Andrew Mould; Karen Lane; Paul J Camarata; Mario Zuccarello; Issam A Awad
Journal:  Neurosurgery       Date:  2017-11-01       Impact factor: 4.654

9.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

Review 10.  Minimally invasive surgery for intracerebral haemorrhage.

Authors:  Benjamin Barnes; Daniel F Hanley; Juan R Carhuapoma
Journal:  Curr Opin Crit Care       Date:  2014-04       Impact factor: 3.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.